Denmark Biotechnology & Medical Research

Gubra A/S (GUBRA)

Track

Over the past 90 days, Gubra A/S recorded three insider transactions, all of which were open-market purchases. Executives, including the CEO and CFO, acquired shares totaling approximately 152,463 DKK. These transactions follow the company's May 2026 results financiers and occur amidst a 19.4% stock price increase over the last quarter.
Ticker: GUBRA Exchange: CPH
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Gubra A/S. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 16 Jun 2026
Value DKK3,491,210.41 | Price 191.22 | Shares 90,991
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-17 2026-06-16 B Purchase
2.5
Markus Rohrwild

Chief Executive Officer

Officer
90,991
191.22
DKK3,491,210 		90,991 191.22 DKK3,491,210
2026-06-17 2026-06-16 B Purchase
Kristian Borbos

Chief Financial Officer

Officer
37,358
240.41
DKK1,052,552 		37,358 240.41 DKK1,052,552
2026-05-11 2026-05-08 B Purchase
1.3
Niels Vrang

Board member in Gubra

Director
15,734
450.57
DKK210,400 		15,734 450.57 DKK210,400
2026-03-02 2026-03-02 B Purchase
1.3
Niels Vrang

Board member

Director
20,000
381.37
DKK7,627,450 		20,000 381.37 DKK7,627,450
2025-12-17 2025-12-17 B Purchase
1.3
Niels Vrang

Board member

Director
10,000
488.00
DKK4,879,977 		10,000 488.00 DKK4,879,977
2025-11-10 2025-11-07 B Purchase
2.3
Monika Lessl

Chairman

Director
379
392.61
DKK148,801 		379 392.61 DKK148,801
2025-11-10 2025-11-07 B Purchase
2.4
Jacob Jelsing

Board member

Director
38,792
386.34
DKK14,987,001 		38,792 386.34 DKK14,987,001
2025-11-07 2025-11-07 B Purchase
2.5
Markus Rohrwild

CEO

Officer
4,300
373.61
DKK1,606,506 		4,300 373.61 DKK1,606,506
Explore more

More insider trading research around Gubra A/S

More insider trades in Denmark
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe